News & Updates

Tenofovir tied to lower risk of severe COVID-19 in HBV patients

18 Jul 2021 by

Patients with chronic hepatitis B virus (HBV) infection who were treated with tenofovir had a lower risk of developing severe COVID-19 illness than those treated with entecavir, according to a study presented at the EASL International Liver Congress (ILC) 2021.

Tenofovir tied to lower risk of severe COVID-19 in HBV patients

18 Jul 2021

COVID-19 infection unlikely to hinder IVF success

17 Jul 2021 by

COVID-19 infection does not appear to adversely affect ovarian reserve, and thus, the chance of success from assisted reproductive treatment likely remains the same as before infection, suggests a small study presented at ESHRE 2021.

COVID-19 infection unlikely to hinder IVF success

17 Jul 2021

Social isolation during COVID-19 impacts comorbidities, mental health

16 Jul 2021 by

Isolation during the COVID-19 pandemic may lead to deterioration in comorbidities and mental health, according to two studies presented at the European Society of Endocrinology virtual conference (e-ECE 2021).

Social isolation during COVID-19 impacts comorbidities, mental health

16 Jul 2021

COVID-19 can lead to cognitive, behavioural issues

10 Jul 2021 by

Some COVID-19 patients experienced cognitive and behavioural problems within 2 months after discharge from hospital, with certain symptoms persisting to 10 months, reveals a longitudinal study presented at EAN 2021.

COVID-19 can lead to cognitive, behavioural issues

10 Jul 2021

Physical frailty predicts death in ILD patients

07 Jul 2021

Patients with interstitial lung disease (ILD) are likely to develop physical frailty, which is independently associated with an increased risk of death, reports a study.

Physical frailty predicts death in ILD patients

07 Jul 2021

Exercise poses respiratory risks in patients with fibrotic ILD

07 Jul 2021

Exercise in patients with interstitial lung disease (ILD) may result in thoracoabdominal asynchrony (TAA) and higher recruitment of inspiratory accessory muscle, suggests a study.

Exercise poses respiratory risks in patients with fibrotic ILD

07 Jul 2021

Lung disease: A risk for COVID-19 severity?

06 Jul 2021 by

Chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) are among respiratory conditions associated with an increased risk of severe COVID-19 outcomes, a recent study showed. However, the impact of respiratory disease on COVID-19 risk may not be as alarming as initially thought.

Lung disease: A risk for COVID-19 severity?

06 Jul 2021

‘PACIFIC regimen’ shows long-term survival benefit with durvalumab in advanced NSCLC

06 Jul 2021 by

Improvements in overall survival (OS) and progression-free survival (PFS) were maintained with durvalumab in patients with unresectable stage III metastatic non-small cell lung cancer (NSCLC), according to updated results of the PACIFIC* trial presented at ASCO 2021.

‘PACIFIC regimen’ shows long-term survival benefit with durvalumab in advanced NSCLC

06 Jul 2021

Real-world data affirms safety, efficacy of omalizumab in severe allergic asthma

05 Jul 2021

Use of omalizumab for treating patients with severe allergic asthma in a real-world setting yields a steroid-sparing effect and helps minimize the occurrence of both clinically significant and severe asthma attacks, as reported in a study.

Real-world data affirms safety, efficacy of omalizumab in severe allergic asthma

05 Jul 2021

Lymphoma patients at high risk of long COVID-19

03 Jul 2021 by

Patients with B-cell non-Hodgkin lymphoma hospitalized for COVID-19 are at an increased risk of developing persistent COVID-19 and death, according to a retrospective study presented at EHA 2021.

Lymphoma patients at high risk of long COVID-19

03 Jul 2021

News & Updates

Filter by Specialty:

Specialty:

Tenofovir tied to lower risk of severe COVID-19 in HBV patients

Tenofovir tied to lower risk of severe COVID-19 in HBV patients

COVID-19 infection unlikely to hinder IVF success

COVID-19 infection unlikely to hinder IVF success

Social isolation during COVID-19 impacts comorbidities, mental health

Social isolation during COVID-19 impacts comorbidities, mental health

COVID-19 can lead to cognitive, behavioural issues

COVID-19 can lead to cognitive, behavioural issues

Physical frailty predicts death in ILD patients

Physical frailty predicts death in ILD patients

Exercise poses respiratory risks in patients with fibrotic ILD

Exercise poses respiratory risks in patients with fibrotic ILD

Lung disease: A risk for COVID-19 severity?

Lung disease: A risk for COVID-19 severity?

‘PACIFIC regimen’ shows long-term survival benefit with durvalumab in advanced NSCLC

‘PACIFIC regimen’ shows long-term survival benefit with durvalumab in advanced NSCLC

Real-world data affirms safety, efficacy of omalizumab in severe allergic asthma

Real-world data affirms safety, efficacy of omalizumab in severe allergic asthma

Lymphoma patients at high risk of long COVID-19

Lymphoma patients at high risk of long COVID-19